TGFB1 and pulmonary arterial hypertension: Several recent studies have implicated TGF-β signaling as a mediator of PAH with increased levels of TGF-β signaling in the lungs of models with PAH, and blocking of its signaling has been shown to reduce the severity of experimental PAH[49–50].